Literature DB >> 25583892

Laryngeal measurements and diagnostic tools for diagnosis of chronic obstructive pulmonary disease.

Verónica Casado1, Sandra M Navarro2, Andrés E Alvarez2, Mercedes Villafañe2, Ana Miranda2, Natalia Spaans2.   

Abstract

PURPOSE: The purpose of this study was to evaluate sensitivity, specificity, and positive and negative likelihood ratios of laryngeal height, lung function, and diagnostic questionnaires for screening and diagnosis of chronic obstructive pulmonary disease (COPD).
METHODS: We undertook a cross-sectional study of 233 people aged between 40 and 75 years. Measured variables were age, sex, weight, height, body mass index, tobacco use, maximum laryngeal height, and spirometry, and we administered a COPD questionnaire and the Lung Function Questionnaire.
RESULTS: For laryngeal height, we found a positive likelihood ratio of 5.21, and for the Lung Function Questionnaire, we found a negative likelihood ratio of 0.10. Combining a maximum laryngeal height of ≤4 cm with Lung Function Questionnaire findings of ≤18 yielded a positive likelihood ratio of 29.06, and a negative likelihood ratio of 0.26.
CONCLUSIONS: The intrinsic validity of the lung function questionnaire makes it useful for screening. Combining Lung Function Questionnaire results and laryngeal height can help confirm or dismiss COPD.
© 2015 Annals of Family Medicine, Inc.

Entities:  

Keywords:  COPD; chronic obstructive pulmonary disease; diagnostic questionnaire; laryngeal measurement

Mesh:

Year:  2015        PMID: 25583892      PMCID: PMC4291265          DOI: 10.1370/afm.1733

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  9 in total

1.  [Geographical variations in the prevalence of COPD in Spain: relationship to smoking, death rates and other determining factors].

Authors:  Joan B Soriano; Marc Miravitlles; Luis Borderías; Enric Duran-Tauleria; Francisco García Río; Jaime Martínez; Teodoro Montemayor; Luis Muñoz; Luis Piñeiro; Guadalupe Sánchez; Joan Serra; Juan José Soler-Cataluña; Antoni Torres; Jose Luis Viejo; Víctor Sobradillo-Peña; Julio Ancochea
Journal:  Arch Bronconeumol       Date:  2010-09-15       Impact factor: 4.872

2.  The accuracy of patient history, wheezing, and laryngeal measurements in diagnosing obstructive airway disease. CARE-COAD1 Group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease.

Authors:  S E Straus; F A McAlister; D L Sackett; J J Deeks
Journal:  JAMA       Date:  2000-04-12       Impact factor: 56.272

3.  Scoring system and clinical application of COPD diagnostic questionnaires.

Authors:  David B Price; David G Tinkelman; Robert J Nordyke; Sharon Isonaka; R J Halbert
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

4.  Does the clinical examination predict airflow limitation?

Authors:  D R Holleman; D L Simel
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272

5.  Does a decision aid help physicians to detect chronic obstructive pulmonary disease?

Authors:  Berna D L Broekhuizen; Alfred Sachs; Kristel Janssen; Geert-Jan Geersing; Karel Moons; Arno Hoes; Theo Verheij
Journal:  Br J Gen Pract       Date:  2011-10       Impact factor: 5.386

6.  Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).

Authors:  Nicola A Hanania; David M Mannino; Barbara P Yawn; Douglas W Mapel; Fernando J Martinez; James F Donohue; Mark Kosinski; Regina Rendas-Baum; Matthew Mintz; Steven Samuels; Priti Jhingran; Anand A Dalal
Journal:  Respir Med       Date:  2010-03-11       Impact factor: 3.415

7.  Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease.

Authors:  Sharon E Straus; Finlay A McAlister; David L Sackett; Jonathan J Deeks
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

8.  External validation of a COPD diagnostic questionnaire.

Authors:  D Kotz; P Nelemans; C P van Schayck; G J Wesseling
Journal:  Eur Respir J       Date:  2007-10-24       Impact factor: 16.671

9.  Accuracy of symptoms, signs, and C-reactive protein for early chronic obstructive pulmonary disease.

Authors:  Berna D L Broekhuizen; Alfred P E Sachs; Theo J Verheij; Kristel J M Janssen; Gerard Asma; Jan-Willem J Lammers; René Hage; Ernst Lammers; Arno W Hoes; Karel G Moons
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

  9 in total
  1 in total

1.  Diagnostic accuracy of screening tools for chronic obstructive pulmonary disease in primary health care: Rapid evidence synthesis.

Authors:  Jyoti Tyagi; Sandeep Moola; Soumyadeep Bhaumik
Journal:  J Family Med Prim Care       Date:  2021-07-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.